http://orcid.org/0000-0001-8649-1311
Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dusica Hadzi Boskovic, Shuting Liang, Purva Parab, Emily Wiggins & Joshua N Liberman. (2023) Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and Outcomes Research 15, pages 487-498.
Read now
Read now
Rezaul Khandker, Farid Chekani, Brendan Limone & Ellen Riehle. (2023) Prevalence and impact of antipsychotic discontinuation among commercially-insured patients with bipolar disorder. Journal of Medical Economics 26:1, pages 878-885.
Read now
Read now
Michael J Doane, Kristine Ogden, Leona Bessonova, Amy K O’Sullivan & Mauricio Tohen. (2021) Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review. Neuropsychiatric Disease and Treatment 17, pages 515-531.
Read now
Read now
Xiaoli Niu, Phani Veeranki, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, G. Rhys Williams & Antony Loebel. (2021) Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data. Current Medical Research and Opinion 37:5, pages 839-846.
Read now
Read now
Articles from other publishers (6)
Michael J. Doane, Kimberly Raymond, Cory Saucier, Leona Bessonova, Amy K. O’Sullivan, Michelle K. White, April Mitchell Foster, Kaitlin LaGasse, Julia Carpenter-Conlin, Martha Sajatovic & Dawn I. Velligan. (2023) Unmet needs with antipsychotic treatment in schizophrenia and bipolar I disorder: patient perspectives from qualitative focus groups. BMC Psychiatry 23:1.
Crossref
Crossref
Sun Lee & Shaina Schwartz. (2021) Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies. Psychiatry Research 306, pages 114277.
Crossref
Crossref
Xiaoli Niu, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, Phani Veeranki, Michael Tocco & G. Rhys Williams. (2021) Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data. Current Therapeutic Research 94, pages 100629.
Crossref
Crossref
Yoo Hyun Um, Tae-Won Kim, Ho-Jun Seo, Seung-Chul Hong, Sung-Min Kim, Ji-Hye Oh & Jong-Hyun Jeong. (2020) Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics. International Clinical Psychopharmacology 35:5, pages 263-269.
Crossref
Crossref
Jens Bohlken, Marcel Konrad & Karel Kostev. (2020) Adherence to neuroleptic treatment in psychiatric practices: A retrospective study of 55 practices with more than 5000 bipolar and schizophrenic patients in Germany. Psychiatry Research 284, pages 112758.
Crossref
Crossref
Michael Musker, Martin David Lewis, Geoffrey Schrader, Vivian Isaac, Jörg Strobel & Niranjan Bidargaddi. (2021) Defining Medication Discontinuation From Prescription Claims Records to Initiate Clinical Intervention in Schizophrenia & Bipolar Disorder: A Systematic Review. SSRN Electronic Journal.
Crossref
Crossref